| AACR Project GENIE: powering precision medicine through an international consortium AACR Project Genie Consortium, AACR Project GENIE Consortium, ... Cancer discovery 7 (8), 818-831, 2017 | 1352 | 2017 |
| Genomic characterization of metastatic breast cancers F Bertucci, CKY Ng, A Patsouris, N Droin, S Piscuoglio, N Carbuccia, ... Nature 569 (7757), 560-564, 2019 | 583 | 2019 |
| Overcoming resistance to tumor-targeted and immune-targeted therapies M Aldea, F Andre, A Marabelle, S Dogan, F Barlesi, JC Soria Cancer discovery 11 (4), 874-899, 2021 | 155 | 2021 |
| 5 S rRNA and tRNA Import into Human Mitochondria: COMPARISON OF IN VITROREQUIREMENTS NS Entelis, OA Kolesnikova, S Dogan, RP Martin, IA Tarassov Journal of Biological Chemistry 276 (49), 45642-45653, 2001 | 150 | 2001 |
| Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by toll-like receptor 4 … J Bernatoniene, Q Zhang, S Dogan, TJ Mitchell, JC Paton, A Finn The Journal of infectious diseases 198 (12), 1823-1833, 2008 | 57 | 2008 |
| Characteristics and Outcome of AKT1E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry LM Smyth, Q Zhou, B Nguyen, C Yu, EM Lepisto, M Arnedos, MJ Hasset, ... Cancer discovery 10 (4), 526-535, 2020 | 45 | 2020 |
| An accessible and unique insight into metastasis mutational content through whole-exome sequencing of circulating tumor cells in metastatic prostate cancer V Faugeroux, C Lefebvre, E Pailler, V Pierron, C Marcaillou, S Tourlet, ... European urology oncology 3 (4), 498-508, 2020 | 37 | 2020 |
| Pneumolysin-induced CXCL8 production by nasopharyngeal epithelial cells is dependent on calcium flux and MAPK activation via Toll-like receptor 4 S Dogan, Q Zhang, AC Pridmore, TJ Mitchell, A Finn, C Murdoch Microbes and infection 13 (1), 65-75, 2011 | 35 | 2011 |
| Implications of selection bias due to delayed study entry in clinical genomic studies S Brown, JA Lavery, R Shen, AS Martin, KL Kehl, SM Sweeney, ... JAMA oncology 8 (2), 287-291, 2022 | 31 | 2022 |
| Overcoming resistance to tumor-targeted and immune-targeted therapies. Cancer Discov. 2021; 11: 874–899. doi: 10.1158/2159-8290 M Aldea, F Andre, A Marabelle, S Dogan, F Barlesi, JC Soria CD-20-1638.[Abstract][CrossRef][Google Scholar], 0 | 27 | |
| Correlation between surrogate end points and overall survival in a multi-institutional clinicogenomic cohort of patients with non–small cell lung or colorectal cancer KL Kehl, GJ Riely, EM Lepisto, JA Lavery, JL Warner, ML LeNoue-Newton, ... JAMA Network Open 4 (7), e2117547-e2117547, 2021 | 19 | 2021 |
| Issues in clinical research for metastatic breast cancer S Dogan, F Andre, M Arnedos Current opinion in oncology 25 (6), 625-629, 2013 | 18 | 2013 |
| Funding sources of practice-changing trials S Dogan, M Yamamoto-Ibusuki, F Andre Annals of Oncology 29 (4), 1063-1065, 2018 | 10 | 2018 |
| Defining research priorities without biases: what is the optimal process? S Dogan, B Pistilli, F Andre Annals of Oncology 28 (2), 195-196, 2017 | 5 | 2017 |
| Whole-exome sequencing of single circulating tumor cells is a useful tool for studying the intrapatient genetic heterogeneity in metastatic prostate cancer. V Faugeroux, C Lefebvre, E Pailler, V Pierron, F Billiot, C Marcaillou, ... Journal of Clinical Oncology 35 (6_suppl), 148-148, 2017 | 4 | 2017 |
| Landscape and evolution of therapeutic research for breast cancer patients S Dogan, MV Dieci, A Goubar, M Arnedos, S Delaloge, F Andre Breast cancer research and treatment 138, 319-324, 2013 | 4 | 2013 |
| Natural History and Characteristics of ERBB2-mutated Hormone Receptor–positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case–control … ML LeNoue-Newton, SC Chen, T Stricker, DM Hyman, N Blauvelt, ... Clinical Cancer Research 28 (10), 2118-2130, 2022 | 3 | 2022 |
| Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer M Bottosso, F Mosele, S Michiels, PH Cournède, S Dogan, C Labaki, ... ESMO open 9 (3), 102247, 2024 | 2 | 2024 |
| Abstract PO2-18-11: Short-term Pre-OPerative Durvalumab (MEDI 4736) in early small triple negative breast cancer patients (POP-Durva) JM Ribeiro, I Pic, Q Blampey, E Rassy, N Ibrahimi, L Salabert, O Trédan, ... Cancer Research 84 (9_Supplement), PO2-18-11-PO2-18-11, 2024 | | 2024 |
| Moving toward precision oncology centers V2. 0 S Dogan, PH Cournède, E Solary, JM Heard, M Aldea, T Conroy, ... Annals of Oncology 34 (12), 1088-1089, 2023 | | 2023 |
